SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-115852
Filing Date
2024-04-26
Accepted
2024-04-26 07:59:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS d796370dars.pdf ARS 1661904
  Complete submission text file 0001193125-24-115852.txt   2290412
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40489 | Film No.: 24878853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)